Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia

Gruppo Italiano Malattie EMatologiche dell'Adulto

Status: Unknown

Conditions: Chronic Myeloid Leukemia

Study type: Observational

Funder types: Other

Identifiers

NCT03075969

QoL-CML 0916

Details and patient eligibility

About

The objective of this study is to test the scale structure, reliability, validity and responsiveness to change of the QLQ-CML24 in conjuction with the QLQ-C30 for patients diagnosed with CML, and to investigate longitudinal relationship between satisfaction with information provision and QoL outcomes.

Enrollment: 337 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Above 18 years of age.
• Patient with confirmed diagnosis of Philadelphia chromosome positive and/or BCR-ABL positive chronic myeloid leukemia (CML).
• Written informed consent.
• Patients enrolled in investigational drug-trials or other type of clinical trials are also eligible.

Exclusion criteria

• Patients with a psychiatric condition or major cognitive impairment (as evaluated by their treating physician) that would hinder completion of self-reported health-related QoL questionnaires.
• Patients who are unable to speak and read the language of the questionnaire.